Sravan Kumar Emany - Net Worth and Insider Trading

Sravan Kumar Emany Net Worth

The estimated net worth of Sravan Kumar Emany is at least $1 Million dollars as of 2024-12-27. Sravan Kumar Emany is the SVP, COO and CFO of Ironwood Pharmaceuticals Inc and owns about 309,572 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $1 Million. Details can be seen in Sravan Kumar Emany's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sravan Kumar Emany has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sravan Kumar Emany

To

Sravan Kumar Emany Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sravan Kumar Emany owns 1 companies in total, including Ironwood Pharmaceuticals Inc (IRWD) .

Click here to see the complete history of Sravan Kumar Emany’s form 4 insider trades.

Insider Ownership Summary of Sravan Kumar Emany

Ticker Comapny Transaction Date Type of Owner
IRWD Ironwood Pharmaceuticals Inc 2024-11-18 SVP & Chief Financial Officer

Sravan Kumar Emany Latest Holdings Summary

Sravan Kumar Emany currently owns a total of 1 stock. Sravan Kumar Emany owns 309,572 shares of Ironwood Pharmaceuticals Inc (IRWD) as of November 18, 2024, with a value of $1 Million.

Latest Holdings of Sravan Kumar Emany

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IRWD Ironwood Pharmaceuticals Inc 2024-11-18 309,572 4.59 1,420,935

Holding Weightings of Sravan Kumar Emany


Sravan Kumar Emany Form 4 Trading Tracker

According to the SEC Form 4 filings, Sravan Kumar Emany has made a total of 4 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 11,001 shares on November 18, 2024, which brought Sravan Kumar Emany around $44,884.

Insider Trading History of Sravan Kumar Emany

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sravan Kumar Emany Trading Performance

GuruFocus tracks the stock performance after each of Sravan Kumar Emany's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sravan Kumar Emany is 1.67%. GuruFocus also compares Sravan Kumar Emany's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sravan Kumar Emany within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sravan Kumar Emany's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sravan Kumar Emany

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.94 LIMIT LIMIT LIMIT LIMIT LIMIT

Sravan Kumar Emany Ownership Network

Ownership Network List of Sravan Kumar Emany

No Data

Ownership Network Relation of Sravan Kumar Emany

Insider Network Chart

Sravan Kumar Emany Owned Company Details

What does Ironwood Pharmaceuticals Inc do?

Who are the key executives at Ironwood Pharmaceuticals Inc?

Sravan Kumar Emany is the SVP & Chief Financial Officer of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include SVP & Chief Business Officer Andrew Davis , Principal Accounting Officer Ronald Silver , and Chief Legal Officer Minardo John .

Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary

Over the past 18 months, Sravan Kumar Emany made 3 insider transaction in Ironwood Pharmaceuticals Inc (IRWD) with a net purchase of 35,755. Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 81,739 shares made by Minardo John , a net sale of 41,218 shares made by Andrew Davis , and a net sale of 12,991 shares made by Ronald Silver .

In summary, during the past 3 months, insiders sold 16,361 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 0 shares, with a net sale of 16,361 shares. During the past 18 months, 559,169 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 505,493 shares.

Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ironwood Pharmaceuticals Inc Insider Transactions

No Available Data

Sravan Kumar Emany Mailing Address

Above is the net worth, insider trading, and ownership report for Sravan Kumar Emany. You might contact Sravan Kumar Emany via mailing address: 100 Summer St, Suite 2300, Boston Ma 02109.

Discussions on Sravan Kumar Emany

No discussions yet.